Red Cross Cited Again

The American Red Cross recently was cited again by the FDA for its failure in keeping the blood supplies safe. Once again, the question is raised as to whether the Red Cross's blood processing department should be sold off. To get background on this problem, read the Red Cross case in my book, Cardinal Principles of Governance. Your comments are welcome.